Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor.
- 1 June 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 13 (6), 791-799
- https://doi.org/10.1161/01.atv.13.6.791
Abstract
S-nitrosothiols may serve as carriers in the mechanism of action of endothelium-derived relaxing factor (EDRF) by stabilizing the labile nitric oxide (NO) radical from inactivation by reactive species in the physiological milieu and by delivering NO to the heme activator site of guanylyl cyclase. Low-molecular-weight thiols, such as cysteine and glutathione, form S-nitrosothiol adducts with vasodilatory and antiplatelet properties, and protein thiols can interact in the presence of NO and/or EDRF to form uniquely stable S-nitroso-proteins. We now show that the S-nitroso-proteins, S-nitroso-albumin, S-nitroso-tissue type plasminogen activator, and S-nitroso-cathepsin B, have potent antiplatelet effects with an IC50 of approximately 1.5 microM. In the dog, S-nitroso-albumin inhibits ex vivo platelet aggregation and significantly prolongs the template bleeding time from 2.15 +/- 0.13 (mean +/- SEM) to 9.70 +/- 1.24 minutes. The antiplatelet action of S-nitroso-proteins is associated with the stimulation of guanylyl cyclase and a significant decrease in fibrinogen binding to platelets. S-Nitroso-proteins undergo thiol-nitrosothiol exchange with low-molecular-weight thiols to form low-molecular-weight S-nitroso-thiols, and they also interact directly with the platelet surface, both of which processes facilitate generation of NO. These data suggest that S-nitroso-proteins are potent antiplatelet agents and may be intermediates in the antiplatelet mechanism of EDRF action.Keywords
This publication has 31 references indexed in Scilit:
- DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its ProgenitorsScience, 1991
- The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disordersJournal of the American College of Cardiology, 1991
- Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator.JCI Insight, 1988
- Oxidation of the 2-hydroxyamino derivative of 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole (Glu-P-1) to its 2-nitroso form, an ultimate form reacting with hemoglobin thiol groupsBiochemical and Biophysical Research Communications, 1988
- The role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumBiochemical and Biophysical Research Communications, 1987
- Demonstration of cGMP‐dependent protein kinase and cGMP‐dependent phosphorylation in cell‐free extracts of plateletsEuropean Journal of Biochemistry, 1986
- Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human plateletsBiochemical and Biophysical Research Communications, 1986
- Metabolic cooperation between vascular endothelial cells and smooth muscle cells in co-culture: changes in low density lipoprotein metabolism.The Journal of cell biology, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- REACTION OF NITRITE WITH SULFHYDRYL GROUPS OF MYOSINJournal of Food Science, 1974